This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2013 Jun;37(6):605-6.

doi: 10.1016/j.leukres.2013.02.017. Epub 2013 Apr 17.

How to treat patients with CMML?

Ulrich Germing, Judith Neukirchen

PMID: 23602358
DOI: 10.1016/j.leukres.2013.02.017

Editorial

How to treat patients with CMML?

Ulrich Germing et al. Leuk Res. 2013 Jun.

. 2013 Jun;37(6):605-6.

doi: 10.1016/j.leukres.2013.02.017. Epub 2013 Apr 17.

Authors

Ulrich Germing, Judith Neukirchen

PMID: 23602358
DOI: 10.1016/j.leukres.2013.02.017

No abstract available

PubMed Disclaimer

Comment on

Predictive factors of response and survival among chronic myelomonocytic leukemia patients treated with azacitidine.
Adès L, Sekeres MA, Wolfromm A, Teichman ML, Tiu RV, Itzykson R, Maciejewski JP, Dreyfus F, List AF, Fenaux P, Komrokji RS. Adès L, et al. Leuk Res. 2013 Jun;37(6):609-13. doi: 10.1016/j.leukres.2013.01.004. Epub 2013 Feb 12. Leuk Res. 2013. PMID: 23415110 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations